| Patents for A61K 38 - Medicinal preparations containing peptides (316,240) |
|---|
| 05/30/1996 | CA2205060A1 Acylated insulin analogs |
| 05/30/1996 | CA2204995A1 Antibiotic cryptdin peptides and methods of their use |
| 05/30/1996 | CA2204850A1 Use of neuregulins as modulators of cellular communication |
| 05/30/1996 | CA2204438A1 Peptides capable of binding to the gap protein sh3 domain, nucleotide sequences coding therefor, and preparation and use thereof |
| 05/30/1996 | CA2204147A1 Methods for treatment of multiple sclerosis using peptide analogs of human myelin basic protein |
| 05/30/1996 | CA2200964A1 Alpha-ketoamide derivatives as cathepsin l inhibitor |
| 05/30/1996 | CA2180529A1 Hemoglobin therapy in hemodialysis |
| 05/29/1996 | EP0713881A2 Use of vWF containing concentrate as combination therapy with antithrombotics and fibrinolytics |
| 05/29/1996 | EP0713705A1 Novel anti-hiv drug |
| 05/29/1996 | EP0713696A1 Topical application product containing a lipase and a precursor of hydroxyacid |
| 05/29/1996 | EP0713532A1 Modified maxadilan protein, its preparation and use, and dna encoding the protein |
| 05/29/1996 | EP0713529A1 NEW GROWTH/DIFFERENTIATION FACTOR OF THE TGF-$g(b) FAMILY |
| 05/29/1996 | EP0713527A1 Fungicidal methods and compositions for killing yeast and sporular microorganisms |
| 05/29/1996 | EP0713496A1 Fibrin-targeted inhibitors of thrombin |
| 05/29/1996 | EP0713495A1 Methods of enhancing bioactivity of chemokines |
| 05/29/1996 | EP0713493A1 Production of human hemoglobin in transgenic pigs |
| 05/29/1996 | EP0713398A1 POLYPEPTIDES CODED BY EXON v5 OF THE CD44 GENE AS TARGETS FOR IMMUNOTHERAPY AND IMMUNOSCINTIGRAPHY OF TUMOURS |
| 05/29/1996 | EP0713396A1 Medical use of stem bromelain protease |
| 05/29/1996 | EP0713395A1 Polymeric carriers for non-covalent drug conjugation |
| 05/29/1996 | EP0679089A4 Methods for promoting cartilage matrix formation. |
| 05/29/1996 | EP0670737A4 In vivo peptide therapy. |
| 05/29/1996 | EP0650364A4 Purification of factor ix. |
| 05/29/1996 | EP0636171A4 Methods of using antibodies against human chorionic gonadotropin-related determinants to lyse, measure and enrich malignant cells. |
| 05/29/1996 | EP0618811A4 Proteolytic mixture containing escharase and method of isolating same. |
| 05/29/1996 | EP0589037B1 Indian derivative and thromboxane antagonist containing the same |
| 05/29/1996 | EP0558647B1 Ligand-mediated immunofunctional hormone binding protein assay method |
| 05/29/1996 | EP0490955B1 Treatment of insulin-resistant diabetes |
| 05/29/1996 | EP0469065B1 Recombinant antibody-toxin fusion protein |
| 05/29/1996 | EP0431129B1 Methods for the inactivation of viruses in viral-contaminated pharmaceutical compositions |
| 05/29/1996 | EP0415924B1 Regulation of cell proliferation and differentiation using peptides |
| 05/29/1996 | CN1123326A Modified gene of human tumor necrotizing factor and its production process |
| 05/29/1996 | CN1123185A Immune couplet |
| 05/29/1996 | CN1031893C A mutant of protein for basic fibroblast growth factor, DNA and use thereof |
| 05/29/1996 | CN1031892C Expression of human proapolipoprotein A-I |
| 05/29/1996 | CN1031880C Process for preparing novel analogs of peptidase substrates |
| 05/28/1996 | US5521302 Nucleophilic reaction of phosphate groups |
| 05/28/1996 | US5521296 Glycoprotein and gene coding therefor |
| 05/28/1996 | US5521295 Nucleic acids encoding hybrid receptor molecules |
| 05/28/1996 | US5521288 CD28IG fusion protein |
| 05/28/1996 | US5521287 Recombinant human serum albumin, process for producing the same and pharmaceutical preparation containing the same |
| 05/28/1996 | US5521286 Bacillus thuringiensis isolate denoted B.t. PS81F, active against lepidopteran pests, and a gene encoding a lepidopteran-active toxin |
| 05/28/1996 | US5521285 CTAA 28A32, the antigen recognized by MCA 28A32 |
| 05/28/1996 | US5521284 Human cancer inhibitory pentapeptide amides and esters |
| 05/28/1996 | US5521283 Anti-obesity proteins |
| 05/28/1996 | US5521179 Heterocyclic amides |
| 05/28/1996 | US5521159 Partially modified and retro-inverted tetrapeptides analogues of C-reactive protein fragments |
| 05/28/1996 | US5521158 Pseudopeptide bradykinin receptor antagonists |
| 05/28/1996 | US5521157 Modified polypeptide compound with VIP-like activity |
| 05/28/1996 | US5521156 Cyclic neurokinin A antagonists |
| 05/28/1996 | US5521155 Antibiotic active against grampositive bacteria |
| 05/28/1996 | US5521154 Imidoester cross-linked hemoglobin compositions |
| 05/28/1996 | US5521153 Synergistic antifungal protein and compositions containing same |
| 05/28/1996 | US5521085 Transformed cell lines producing human monoclonal antibodies specific for Pseudomonas aeruginosa serotypes |
| 05/28/1996 | US5521076 Modified hepatocytes and uses therefor |
| 05/28/1996 | US5521073 Genetic vectors for cell expression |
| 05/28/1996 | US5521071 Soluble LDL receptor and gene |
| 05/28/1996 | US5521070 DNA sequence coding for human factor IX or a similar protein, expression vector, transformed cells, method for preparing factor IX and corresponding products obtained |
| 05/28/1996 | US5521067 Bone marrow cell adhesion molecules and process for detecting adherence between cell adhesion molecules and cells generally |
| 05/28/1996 | US5520948 High acid system nutritional formulations |
| 05/28/1996 | US5520927 Method for the preparation of sustained release somatotropin and product produced thereby |
| 05/28/1996 | US5520923 Formulations for delivery of osteogenic proteins |
| 05/28/1996 | US5520914 Antibodies to angiogenin: immunotherapeutic agents |
| 05/28/1996 | US5520913 Tissue plasminogen activator having zymogenic properties |
| 05/28/1996 | US5520912 Prevention and treatment of ischemic events and reperfusion injury resulting therefrom using lys-plasminogen |
| 05/28/1996 | US5520885 Fibrinogen processing apparatus, method and container |
| 05/28/1996 | CA2078996C A bifunctional dtpa-type ligand |
| 05/24/1996 | CA2163379A1 Nutritional composition containing improved dietary nitrogen component |
| 05/23/1996 | WO1996015272A1 Neural thread protein gene expression and detection of alzheimer's disease |
| 05/23/1996 | WO1996015267A1 Rapid detection and identification of nucleic acid variants and pathogens |
| 05/23/1996 | WO1996015265A1 METHODS FOR MODULATING TRANSCRIPTION FROM THE AMYLOID β-PROTEIN PRECURSOR (APP) PROMOTER |
| 05/23/1996 | WO1996015249A1 High level expression and facile purification of proteins, peptides and conjugates for immunization, purification and detection applications |
| 05/23/1996 | WO1996015247A1 Purified papillomavirus proteins |
| 05/23/1996 | WO1996015245A1 A process of inhibiting non-neoplastic pathological cell proliferation |
| 05/23/1996 | WO1996015244A2 Sensory and motor neuron derived factor (smdf) |
| 05/23/1996 | WO1996015243A1 Transcription factor e2f-4 |
| 05/23/1996 | WO1996015242A2 Methods for inhibiting cell proliferation by inhibiting the mitogenic activity of macrophage migration inhibitory factor |
| 05/23/1996 | WO1996015240A2 Ribozyme analogs |
| 05/23/1996 | WO1996015238A1 Targeted t lymphocytes |
| 05/23/1996 | WO1996015234A2 Lipid-splitting enzyme |
| 05/23/1996 | WO1996015227A1 Methods of inducing cell death of primitive hematopoietic cells and compositions for induction thereof |
| 05/23/1996 | WO1996015226A1 Regulation of neural stem cell proliferation |
| 05/23/1996 | WO1996015224A1 In vitro induction of dopaminergic cells |
| 05/23/1996 | WO1996015222A1 HUMAN MutT2 |
| 05/23/1996 | WO1996015153A1 Human antibodies to t-cell receptor peptides and methods for their preparation |
| 05/23/1996 | WO1996015151A1 Purification of hemoglobin |
| 05/23/1996 | WO1996015150A1 Process for purifying factor viii |
| 05/23/1996 | WO1996015148A2 Low molecular weight peptidomimetic growth hormone secretagogues |
| 05/23/1996 | WO1996015147A1 Human stanniocalcin-alpha |
| 05/23/1996 | WO1996015146A1 Conjugates of bdnf and nt-3 with a water-soluble polymer |
| 05/23/1996 | WO1996015145A1 BETA3 INTEGRIN SUBUNIT SPECIFIC POLYPEPTIDES, cDNAs WHICH ENCODE THESE POLYPEPTIDES AND METHODS OF PRODUCING THESE POLYPEPTIDES |
| 05/23/1996 | WO1996015143A1 SYNTHESIS OF PEPTIDE NUCLEIC ACIDS (PNAs) AND ANALOGUES VIA SUBMONOMER APPROACH |
| 05/23/1996 | WO1996015141A1 Cholesteryl ester transfer protein inhibitor peptides and prophylactic and therapeutic anti-arteriosclerosis agents |
| 05/23/1996 | WO1996015140A1 Process for purification of factor viii |
| 05/23/1996 | WO1996014877A1 Novel tumor suppressor gene, hic-1 |
| 05/23/1996 | WO1996014876A1 Yeast-based delivery vehicles |
| 05/23/1996 | WO1996014874A1 Method for gene therapy involving suppression of an immune response |
| 05/23/1996 | WO1996014873A2 COVALENTLY BOUND β-GLUCAN CONJUGATES IN TARGETED DELIVERY |
| 05/23/1996 | WO1996014871A1 Immunogenic compositions |
| 05/23/1996 | WO1996014867A1 Dna encoding canine immunoglobulins |
| 05/23/1996 | WO1996014865A1 Methods for inhibiting graft versus host disease in bone marrow transplantation |